TOP STORIES

• BUSINESS CNS Alliance with Otsuka Expected to be Long-term: Sumitomo Dainippon Senior Executive
  October 28, 2021

• BUSINESS Sun Pharma Japan to Boost Sales Force, Development to Achieve 1.5-Fold Sales Growth by 2025
  October 27, 2021

• COMMENTARY SGLT2 Inhibitors, Entresto Could Change Paradigm of Treatment of Heart Failure: JHFS Annual Confab
  October 26, 2021

• BUSINESS KM Biologics Eyes COVID-19 Booster Filing as Early as Spring, Trial Start Slated by Year-End
  October 26, 2021

• ORGANIZATION Main Focus of INES Proposal Is Securing Resources to Reward Innovation, Not Macroeconomic Indexing
  October 25, 2021

• BUSINESS Mundipharma Japan Set to Cut into High Production Costs, Boost Profitability to Lure Investments: President
  October 22, 2021

• ACADEMIA Japan Headache Society Clarifies Patients Suitable for CGRP Migraine Meds, No Drug Selection Criteria Given for Now
  October 21, 2021

• REGULATORY Average Price Gap for FY2022 Revision Likely to Be 8% Level or Lower: Wholesalers
  October 20, 2021

• COMMENTARY LDP’s Pharma Study Group at Critical Juncture as Kishida Vows to Rectify Power Balance, Kingpins Retire
  October 19, 2021

• BUSINESS Veklury Now Available in Normal Distribution Channel in Japan
  October 19, 2021

• BUSINESS Alfresa to Introduce Digital-Driven Deliveries at All Offices by August 2024; Test Run Showing Good Results
  October 18, 2021

• COMMENTARY Drug Makers Downsizing Sales Forces to Increase Efficiency; Launch of Redundancy Programs to Be Continued
  October 15, 2021

• ORGANIZATION Choseido Suspended from JGA for 5 Years after Biz Suspension Order
  October 15, 2021

• ORGANIZATION EFPIA to Ponder Position on Macroeconomic Indexing with Patient Access as Top Priority, Continue Dialogue with Japan Govt
  October 14, 2021

• COMMENTARY Pharma on Alert for Possible Repeat of Minister Deal on Drug Pricing Reform
  October 13, 2021

• BUSINESS Japan Drug Makers Prepping to Launch New Organization to Solve Challenges in Digital Health
  October 13, 2021

• REGULATORY Choseido Woes Cast Clouds on Generic Inroads in Tokushima, Worst Player in Penetration
  October 12, 2021

• BUSINESS Chugai Seeks Japan Nod for Ronapreve in Prophylaxis, Asymptomatic COVID-19
  October 12, 2021

• BUSINESS Ivermectin COVID-19 Trial Needed Because Evidence Is Lacking, Kowa Says as It Aims for PIII Wrap-Up in November
  October 11, 2021

• REGULATORY MHLW Orders Large-Scale Carcinogen Risk Inspections, Covering Almost All Drugs
  October 11, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 79
• 80
• 81
• 82
• 83
• 84
• 85
• 86
• 87
• …
• Next ›
• 最終 »